Bruker/$BRKR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bruker
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
- Ticker
- $BRKR
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 11,085
- Headquarters
- Billerica, United States
- Website
- www.bruker.com
Bruker Metrics
BasicAdvanced
$9bn
-
-$0.70
1.28
$0.20
0.34%
Price and volume
Market cap
$9bn
Beta
1.28
52-week high
$65.30
52-week low
$28.53
Average daily volume
2.4m
Dividend rate
$0.20
Financial strength
Current ratio
1.847
Quick ratio
0.607
Long term debt to equity
74.501
Total debt to equity
76.164
Interest coverage (TTM)
7.59%
Profitability
EBITDA (TTM)
541.1
Gross margin (TTM)
48.56%
Net profit margin (TTM)
-2.03%
Operating margin (TTM)
8.89%
Effective tax rate (TTM)
-167.63%
Revenue per employee (TTM)
$320,000
Management effectiveness
Return on assets (TTM)
3.14%
Return on equity (TTM)
-3.00%
Valuation
Price to revenue (TTM)
2.576
Price to book
3.76
Price to tangible book (TTM)
-12.65
Price to free cash flow (TTM)
278.241
Free cash flow yield (TTM)
0.36%
Free cash flow per share (TTM)
0.213
Dividend yield (TTM)
0.34%
Forward dividend yield
0.34%
Growth
Revenue change (TTM)
1.65%
Earnings per share change (TTM)
-234.94%
3-year revenue growth (CAGR)
8.84%
10-year revenue growth (CAGR)
8.00%
3-year earnings per share growth (CAGR)
-31.27%
10-year earnings per share growth (CAGR)
0.57%
10-year dividend per share growth (CAGR)
9.60%
What the Analysts think about Bruker
Analyst ratings (Buy, Hold, Sell) for Bruker stock.
Bruker Financial Performance
Revenues and expenses
Bruker Earnings Performance
Company profitability
Bruker News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.